Fundraising FoxCoapt LLC
1 known investors
Find your way into Coapt LLC
Sign up to see every warm intro you have to Coapt LLC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Coapt LLC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Coapt develops myoelectric pattern recognition control systems for upper limb prostheses, using machine learning algorithms to decode residual muscle signals and translate a user's intended movements into prosthetic control. Its device-agnostic Complete Control Gen2 system serves people with upper limb loss or difference and the clinicians who fit them, working with the majority of powered upper-limb prosthetic components.
Investors · 1
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $986.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $999.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $143.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $984.2K |
| Department of DefenseDefense Health Program | Phase I | 2014 | $148.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $150.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Coapt LLC do?
- Coapt develops myoelectric pattern recognition control systems for upper limb prostheses, using machine learning algorithms to decode residual muscle signals and translate a user's intended movements into prosthetic control. Its device-agnostic Complete Control Gen2 system serves people with upper limb loss or difference and the clinicians who fit them, working with the majority of powered upper-limb prosthetic components.
- Who are Coapt LLC's investors?
- Coapt LLC's investors include Saints Capital.